Sudan: Intense fighting is forcing hospitals to close in El Fasher
story Jun 13, 2024
Get the latest news, stories, videos, and more from our medical humanitarian projects around the world.
story Jun 13, 2024
Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.
Story | Mar 25, 2024
The scale of the crisis is beyond the capacity of any single organization and requires urgent and coordinated action from the international community.
Read MoreStory | Mar 22, 2024
MSF and activists launch a petition and protest outside Danaher in Washington, DC to pressure companies to reduce the price of lifesaving medical tests.
Read MoreStory | Mar 20, 2024
As leaders meet this week to negotiate the global “pandemic accord," the US must do more to ensure we are prepared for future public health emergencies.
Read MoreNews | Mar 19, 2024
Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries.
Read MoreStory | Mar 18, 2024
An MSF project in Portel, Brazil aims to overcome obstacles so Amazonian communities can access health care.
Read MoreStory | Mar 12, 2024
As fighting displaces thousands of people in North and South Kivu, concerns grow about the spread of disease due to overcrowded, unsanitary living conditions.
Read MoreStory | Mar 11, 2024
MSF's head of mission describes people living in fear in a city still at war.
Read MoreNews | Mar 08, 2024
The US should insist on immediate humanitarian access using existing roads and entry points.
Read MoreResearch | Mar 07, 2024
A survey conducted by MSF’s Epicentre shows an abnormally high mortality rate, with more than 40 percent of all deaths caused by violence.
Read MoreStory | Feb 27, 2024
Restrictions on aid and a lack of protection for humanitarian staff makes it nearly impossible to provide care in Gaza.
Read MoreYour unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.